135 related articles for article (PubMed ID: 6150769)
1. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
Gotschlich EC
Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
[TBL] [Abstract][Full Text] [Related]
2. [Gonococcal surface antigens and their significance for serotyping and vaccines].
Kohl PK; Meyer TF; Petzoldt D
Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
[TBL] [Abstract][Full Text] [Related]
3. Evasion mechanisms of pathogenic Neisseriae.
Meyer TF
Behring Inst Mitt; 1991 Feb; (88):194-9. PubMed ID: 1688359
[TBL] [Abstract][Full Text] [Related]
4. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
Sparling PF; Cannon JG; So M
J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125
[No Abstract] [Full Text] [Related]
5. Gonococci are survivors.
Sparling PF; Tsai J; Cornelissen CN
Scand J Infect Dis Suppl; 1990; 69():125-36. PubMed ID: 2124726
[TBL] [Abstract][Full Text] [Related]
6. The sixth C. L. Oakley lecture. Molecular studies on the pathogenesis of gonorrhoea.
Heckels JE
J Med Microbiol; 1984 Dec; 18(3):293-307. PubMed ID: 6209398
[No Abstract] [Full Text] [Related]
7. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency.
Robbins JB
Br J Vener Dis; 1977 Jun; 53(3):170-2. PubMed ID: 406011
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic mechanisms of organisms virulent to the eye.
Watt PJ
Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 1)():26-31. PubMed ID: 2872741
[TBL] [Abstract][Full Text] [Related]
9. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
Rothbard JB; Schoolnik GK
Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
[No Abstract] [Full Text] [Related]
10. Understanding the structure and antigenicity of gonococcal pili.
Getzoff ED; Parge HE; McRee DE; Tainer JA
Rev Infect Dis; 1988; 10 Suppl 2():S296-9. PubMed ID: 2903537
[TBL] [Abstract][Full Text] [Related]
11. Biology of the Gonococcus: Disease and Pathogenesis.
Shaughnessy J; Ram S; Rice PA
Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
[TBL] [Abstract][Full Text] [Related]
12. Common pathways of invasion of mucosal barriers by Neisseria gonorrhoeae and Neisseria meningitidis.
McGee ZA; Stephens DS
Surv Synth Pathol Res; 1984; 3(1):1-10. PubMed ID: 6150544
[No Abstract] [Full Text] [Related]
13. The status of vaccines to meningococcal and gonococcal disease.
Gotschlich EC
Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):341-55. PubMed ID: 2870677
[TBL] [Abstract][Full Text] [Related]
14. [Antigenic and immunogenic properties of the pili and external wall of the gonococcus].
Ovchinnikov NM; Delektorskiĭ VV; Timchenko GF; Dmitriev GA
Vestn Dermatol Venerol; 1981 Jul; (7):11-5. PubMed ID: 6117164
[No Abstract] [Full Text] [Related]
15. Questions about gonococcal pilus phase- and antigenic variation.
Seifert HS
Mol Microbiol; 1996 Aug; 21(3):433-40. PubMed ID: 8866467
[TBL] [Abstract][Full Text] [Related]
16. Vaccine research for gonococcal infections: where are we?
Jerse AE; Deal CD
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
[TBL] [Abstract][Full Text] [Related]
17. Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea.
Zak K; Diaz JL; Jackson D; Heckels JE
J Infect Dis; 1984 Feb; 149(2):166-74. PubMed ID: 6142073
[TBL] [Abstract][Full Text] [Related]
18. [The therapeutic efficacy of a gonococcal vaccine].
Andreeva ZM; Bednova VN; Shevchenko NM; Malyshev AM; Danilenko TI
Vestn Dermatol Venerol; 1989; (11):53-5. PubMed ID: 2515676
[TBL] [Abstract][Full Text] [Related]
19. The pilin O-glycosylation pathway of pathogenic Neisseria is a general system that glycosylates AniA, an outer membrane nitrite reductase.
Ku SC; Schulz BL; Power PM; Jennings MP
Biochem Biophys Res Commun; 2009 Jan; 378(1):84-9. PubMed ID: 19013435
[TBL] [Abstract][Full Text] [Related]
20. [Antigenic composition of the gonococcal strains used in preparing a gonorrhea vaccine].
Andreeva ZM; Shevchenko NM
Vestn Dermatol Venerol; 1986; (7):33-5. PubMed ID: 3094267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
